'I would put us up against mRNA': Novavax sets out vision for vaccine success in COVID and beyond

Despite mRNA powerhouses Pfizer and Moderna continuing to tower over the COVID-19 vaccine market, there still are plenty of biotechs hoping to carve off a slice. When they took to the stage at the Jefferies Healthcare London Conference this week, these newer players were asked the same billion-dollar question: What sets you apart?